North American Scientific will showcase its ClearPath, a high-dose rate radiation treatment created for breast brachytherapy, aiming to enhance current accelerated partial breast irradiation (APBI) treatment options. The company’s multichannel catheter system, which is inserted through a single incision, is designed to allow for low-dose or high-dose therapy. ClearPath reportedly offers physicians greater flexibility in treatment planning and dose optimization to the target region, while minimizing exposure to nearby healthy tissue.
Technology | July 10, 2007
NAS Highlights Versatile Radiation Therapy System
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Videos | Brachytherapy Systems, Women's Healthcare | November 07, 2018
An interview with...
Videos | Radiation Oncology | November 07, 2018
Aadel Chaudhuri, M.D., assistan
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more